Fiasp 100IU/ml Solution for Injection contains Insulin Aspart, a rapid-acting insulin analog used to improve glycemic control in adults and children with diabetes mellitus. This medication is designed to be administered subcutaneously to manage blood glucose levels in patients with type 1 and type 2 diabetes. Insulin Aspart works by mimicking the body's natural insulin response, facilitating the uptake of glucose into muscle and fat cells, thereby lowering blood sugar levels after meals. Fiasp has a faster onset of action compared to regular insulin as it begins to work approximately 2.5 minutes after injection, making it particularly effective for controlling postprandial hyperglycemia. The solution is clear and colorless, supplied in pre-filled pens or vials, and should be used as part of a comprehensive diabetes management plan that includes diet and exercise. Dosage and timing should be individualized based on blood glucose monitoring and physician guidance. Patients must be educated on proper injection techniques and hypoglycemia recognition. Fiasp should not be mixed with other insulins in the same syringe. Proper storage between 2°C and 8°C is essential to maintain efficacy. Consult healthcare professionals before use to ensure safe and effective diabetes management.